$CFOR Cashflow Statement | Understand Stock

$CFOR

$5.15 -$0.00 (0.02%) Close

$CFOR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization
Noncash interest expense
Change in inventory reserve
Stock compensation expense
Loss on sale of equipment
Gain on extinguishment of debt
Warrant inducement expense
Cash bonus taken in the form of stock compensation
Loss on deconsolidation of subsidiaries

Change in fair value of derivative financial instruments
Change in fair value of EIB loan guaranty
Gain on impairment adjustment
Gain on settlement of compensation expense
Impairment of right-of-use asset
Impairment of property and equipment
Impairment of intangible assets
Impairment expense of goodwill
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Other assets
Prepaid expenses and other current assets
Deferred offering costs
Investments
Accounts payable
Accrued compensation and benefits
Accrued liabilities
Operating lease liabilities
Deferred revenue
Net cash used in operating activities
Cash flows from investing activities:
Net cash acquired in business combination
Purchase of intangible asset
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock warrants
Proceeds from issuance of common stock and pre-funded warrants in registered direct offering, net of selling costs
Proceeds from the exercise of common warrants
Proceeds from issuance of common stock and warrants, net of issuance cost
Proceeds from at the market offering, net of issuance costs
Proceeds from issuance of common stock and warrants, net of issuance costs
Proceeds from issuance of common stock and pre-funded warrants in registered direct offering, net of issuance costs
Proceeds from issuance of common stock, net of issuance costs
Proceeds from issuance of preferred stock, net of issuance costs
Proceeds from short-term insurance financing
Payments on short-term insurance financing
Payments on debt
Payments on finance lease obligations

Net cash provided by financing activities
Effects of exchange rates on cash
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash and cash equivalents and restricted cash at beginning of year
Cash and cash equivalents and restricted cash at end of year
Supplemental disclosure of cash flow information
Cash paid for interest
Supplemental disclosures of non-cash investing and financing activities
Deemed dividend – beneficial conversion option on preferred stock
Inventory transferred to property and equipment
Settlement of deferred compensation and severance
Issuance of common stock upon conversion of preferred stock
Right-of-use assets acquired through operating leases
Purchased equipment not yet paid for
Property and equipment transferred to inventory
Common stock issuable pursuant to acquisition

Comments